Erlotinib and malignant neoplasm progression 
Erlotinib and malignant neoplasm progression Patient Reports February 11, 2012
Erlotinib Side Effects Report #5946016-5
Erlotinib side effect was reported by a Physician from JAPAN on Oct 24, 2008. Female patient, 70 years of age, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: amnesia, anxiety
, aspiration, delirium, disorientation, malignant neoplasm progression, pneumonia bacterial, respiratory failure, restlessness. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with GENINAX, LASIX, ALDACTONE, PURSENNID, LOSARTAN POTASSIUM, DOGMATYL, ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE, FERROMIA. Patient was hospitalized. Patient died on 04/05/2008.Erlotinib Side Effects Report #5803938-3
Erlotinib side effect was reported by a Physician from SPAIN on June 18, 2008. Female patient, 76 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, gastrointestinal toxicity, malignant neoplasm progression, nausea
, pancreatic carcinoma. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, LOPERAMIDA, EPOETIN BETA, NEUPOGEN, BUPRENORFINE HYDROCHLORIDE, METAMIZOL MAGNESIUM, FENTANILO, ENOXAPARIN. Patient was hospitalized. Patient died on 02/09/2008.Erlotinib Side Effects Report #5142884-8
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Oct 20, 2006. Male patient, 70 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: back pain
, fall , malignant neoplasm progression, muscular weakness. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, DOCUSATE, METFORMIN, ASPIRIN, DEXAMETHASONE, OMEPRAZOLE, DILTIAZEM. Patient was hospitalized. Patient died on 08/27/2006.Erlotinib Side Effects Report #5487509-7
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Sept 28, 2007. Male patient, 70 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: back pain
, fall , malignant neoplasm progression, metastatic neoplasm, muscular weakness. Erlotinib dosage: 50 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, DOCUSATE, METFORMIN, ASPIRIN, DEXAMETHASONE, OMEPRAZOLE, DILTIAZEM. Patient was hospitalized. Patient died on 08/27/2006.Erlotinib Side Effects Report #5020133-9
Erlotinib side effect was reported by a Physician from GERMANY on May 26, 2006. Female patient, 63 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pancreatic carcinoma metastatic. Erlotinib dosage: 100 MG (QD) ORAL. During the same period patient was treated with AVASTIN, GEMCITABINE. Patient died on 04/27/2006.
Erlotinib Side Effects Report #5698598-9
Erlotinib side effect was reported by a Physician from CANADA on Mar 21, 2008. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: injury, malignant neoplasm progression, thrombotic microangiopathy, urine output decreased. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient died.
Erlotinib Side Effects Report #5224125-6
Erlotinib side effect was reported by a Health Professional from NETHERLANDS on Jan 10, 2007. Male patient, 57 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anal fistula, malignant neoplasm progression, myocardial infarction, myocardial ischaemia, pancreatic carcinoma metastatic, sepsis
. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5245531-X
Erlotinib side effect was reported by a Consumer or non-health professional from NETHERLANDS on Feb 01, 2007. Male patient, 57 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anal abscess, anal fistula, malignant neoplasm progression, myocardial infarction, myocardial ischaemia, pancreatic carcinoma, sepsis
. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5223021-8
Erlotinib side effect was reported by a Physician from SWEDEN on Jan 09, 2007. Male patient, 51 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pancreatic carcinoma metastatic. Erlotinib dosage: 100 MG QD, ORAL. During the same period patient was treated with GEMCITABINE, NOVOMIX, CIPROFLOXACIN, CITODON, MORPHINE SULPHATE, EBASTINE, CAPECITABINE. Patient died on 12/24/2006.
Erlotinib Side Effects Report #5819961-9
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2008. Female patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: candidiasis, dyspnoea, lung infection, malignant neoplasm progression, metastases to lung, oxygen saturation decreased, pyrexia. Erlotinib dosage: 150 MG, QD, DAYS 1-28, ORAL. During the same period patient was treated with SORAFENIB, GEMCITABINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5191038-8
Erlotinib side effect was reported by a Physician from SPAIN on Dec 04, 2006. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gallbladder disorder, jaundice cholestatic, malignant neoplasm progression. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, FENTANYL, ENOXAPARIN, GABAPENTINA, LEXATIN, FORTASEC, PRIMPERAN. Patient was hospitalized. Patient died on 10/24/2006.
Erlotinib Side Effects Report #6053251-7
Erlotinib side effect was reported by a Physician from FRANCE on Jan 07, 2009. Female patient, 62 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, anorexia, dysphonia, escherichia sepsis, malignant neoplasm progression, nausea , vocal cord paralysis. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, IMOVANE, PROPRANOLOL, DURAGESIC, ACTISKENAN, PRIMPERAN, ZOFRAN, FORTIMEL. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5301498-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 27, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pancreatic carcinoma metastatic, pulmonary embolism
. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized and became disabled. Patient recovered.Erlotinib Side Effects Report #5776006-7
Erlotinib side effect was reported by a Physician from UNITED STATES on May 29, 2008. Male patient was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, ascites, chills, hyperglycaemia, hyponatraemia, malignant neoplasm progression, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with EVEROLIMUS. Patient was hospitalized. Patient died on 05/18/2008.
Erlotinib Side Effects Report #5868599-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 15, 2008. Female patient was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gastrointestinal perforation, malignant neoplasm progression, small intestinal obstruction. Erlotinib dosage: (150 MG, QD) ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5224126-8
Erlotinib side effect was reported by a Physician from DENMARK on Jan 12, 2007. Male patient, 54 years of age, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abnormal faeces, decubitus ulcer, gastric haemorrhage, haemorrhagic disorder, hepatic failure, ill-defined disorder, laboratory test abnormal, malignant neoplasm progression, metastases to liver. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, ATENOLOL, DURAGESIC, PINEX, AMLODIPINE, CITALOPRAM HYDROBROMIDE, PANTOPRAZOLE, PREDNISOLONE. Patient was hospitalized. Patient died on 10/06/2006.
Erlotinib Side Effects Report #5691881-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 01, 2008. Male patient, 84 years of age, weighting 141.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain upper, anaemia, anorexia, back pain
, constipation , failure to thrive, malignant neoplasm progression, rash , weight decreased. Erlotinib dosage: 150 MG DAILY 047 PO. During the same period patient was treated with BEVACIZUMAB, HYTRIN, ZOCOR, NEURONTIN, GEMFIBROZIL, NORTRIPTYLINE, GLYBURIDE AND METFORMIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6120790-X
Erlotinib side effect was reported by a Physician from JAPAN on Feb 26, 2009. Female patient, 84 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: concomitant disease progression, lung adenocarcinoma, malignant neoplasm progression. Erlotinib dosage: (150 MILLICURIES,QD),ORAL. During the same period patient was treated with AMLODIPINE BESYLATE, OLMETEC, COMELIAN, MAGNESIUM OXIDE, BENFOTIAMINE. Patient died on 01/12/2009.
Erlotinib Side Effects Report #4950266-4
Erlotinib side effect was reported by a Physician from GERMANY on Feb 28, 2006. Male patient, 80 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, non-small cell lung cancer. Erlotinib dosage: unknown. Patient died on 05/10/2005.
Erlotinib Side Effects Report #6060242-9
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 14, 2009. Male patient, 78 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypotension, lower respiratory tract infection, malignant neoplasm progression, non-small cell lung cancer, pneumonia
. Erlotinib dosage: (150 MG, QD) ,ORAL. Patient was hospitalized. Patient died on 01/01/2009.Erlotinib Side Effects Report #4961633-7
Erlotinib side effect was reported by a Physician from GERMANY on Mar 13, 2006. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, non-small cell lung cancer. Erlotinib dosage: 150 MG (QD), ORAL. Patient died on 09/01/2005.
Erlotinib Side Effects Report #5670074-9
Erlotinib side effect was reported by a Physician from GERMANY on Feb 26, 2008. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: constipation
, dehydration, fall , infection , malignant neoplasm progression, nausea . Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with OXYCODONE, MOVICOL, NEXIUM, NOVALGIN, INSULIN, METOCLOPRAMID, SPIRONOLACTONE. Patient was hospitalized. Patient died on 01/20/2007.Erlotinib Side Effects Report #5194057-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 11, 2006. Male patient, 73 years of age, weighting 181.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acute prerenal failure, diabetes mellitus inadequate control, dysarthria, hyperglycaemia, hypovolaemia, malignant neoplasm progression, muscle twitching, non-small cell lung cancer, postoperative renal failure. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DECADRON, ASPIRIN, ZYRTEC, ALFUZOSIN, PLAVIX, LASIX, FLOXIL, ZOCOR. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5935306-8
Erlotinib side effect was reported by a Physician from MEXICO on Oct 20, 2008. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, malignant neoplasm progression. Erlotinib dosage: (150 MG, QD), ORAL. Patient died on 10/29/2006.
Erlotinib Side Effects Report #5244800-7
Erlotinib side effect was reported by a Physician from SWITZERLAND on Feb 02, 2007. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: hemiparesis, malignant neoplasm progression, syncope. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, ASPIRIN, FRAGMIN. Patient was hospitalized. Patient died on 12/30/2006.
Erlotinib Side Effects Report #6024147-1
Erlotinib side effect was reported by a Physician from GERMANY on Dec 17, 2008. Female patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, diarrhoea, erythema, gamma-glutamyltransferase increased, hepatotoxicity, malignant neoplasm progression, non-small cell lung cancer. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with TRAMADOL HYDROHLORIDE, PANTOPRAZOLE, NOVALGIN, VOLTAREN, ECURAL. Patient was hospitalized. Patient died on 11/24/2008.
Erlotinib Side Effects Report #6060244-2
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 14, 2009. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchopneumonia, cardiac failure congestive, malignant neoplasm progression, mucosal inflammation, non-small cell lung cancer, pleural effusion, pulmonary embolism
, rash . Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with ASPIRIN, AMLODIPINE, LACTULOSE, DOMPERIDONE, DIGOXIN, DILTIAZEM, FUROSEMIDE, DEXAMETHASONE. Patient was hospitalized. Patient died on 10/17/2008.Erlotinib Side Effects Report #4781644-4
Erlotinib side effect was reported by a Physician from GERMANY on Sept 12, 2005. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, malignant neoplasm progression, metastases to lung, non-small cell lung cancer, rash
, vision blurred, visual disturbance. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with SPIRONOLACTONE, FUROSEMIDE, ACETYLCYSTEINE, ASPIRIN, PREDNISONE, ALBUTEROL SULPHATE, ZOMETA. Patient was hospitalized and became disabled. Patient recovered.Erlotinib Side Effects Report #4851118-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 01, 2005. Female patient, 67 years of age, weighting 173.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bacterial infection
, dilatation atrial, dysphagia, lymphangitis, malignant neoplasm progression, non-small cell lung cancer stage iv, pleural effusion, pulmonary hypertension , sputum culture positive. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AVASTIN, PREDNISONE, COMBIVENT, NORVASC. Patient was hospitalized and became disabled. Patient died on 11/18/2005.Erlotinib Side Effects Report #4931344-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 21, 2006. Female patient, 67 years of age, weighting 173.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, breath sounds abnormal, cough, crepitations, dilatation atrial, lung infiltration, malignant neoplasm progression, non-small cell lung cancer, orthopnoea. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AVASTIN, PREDNISONE, COMBIVENT, NORVASC. Patient was hospitalized and became disabled. Patient died on 11/18/2005.
Erlotinib Side Effects Report #4832421-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 02, 2005. Male patient, 66 years of age, weighting 151.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dehydration, haemoptysis, malignant neoplasm progression, non-small cell lung cancer. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AVASTIN. Patient died on 11/01/2005.
Erlotinib Side Effects Report #6058146-0
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 13, 2009. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, fluid intake reduced, hypoxia, lethargy, malignant neoplasm progression, mobility decreased, pleural effusion, pneumonia
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with NYSTATIN, CITALOPRAM HYDROBROMIDE, LORAZEPAM, OXYCODONE. Patient was hospitalized. Patient died on 07/23/2008.Erlotinib Side Effects Report #5237023-9
Erlotinib side effect was reported by a Physician from SWEDEN on Jan 26, 2007. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, diarrhoea, haemoptysis, lung neoplasm malignant, malignant neoplasm progression, malnutrition, nausea
, performance status decreased. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with OXYCONTIN, PREDNISOLONE, ACETAMINOPHEN, COZAAR, METOPROLOL TARTRATE, KLEXANE, IMOVANE, OXYCODONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5362706-X
Erlotinib side effect was reported by a Physician from SWEDEN on May 29, 2007. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, lung neoplasm malignant, malignant neoplasm progression, malnutrition, nausea
, pain , performance status decreased. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with OXYCONTIN, PREDNISOLONE, ACETAMINOPHEN, COZAAR, METOPROLOL TARTRATE, ENOXAPARIN, IMOVANE, OXYCODONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5526191-7
Erlotinib side effect was reported by a Physician from SWEDEN on Nov 06, 2007. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, lung neoplasm malignant, malignant neoplasm progression, malnutrition, metastases to bone, nausea
, pain . Erlotinib dosage: 150 MG (150 MG,QD), ORAL. During the same period patient was treated with OXYCONTIN, PREDNISONE, ACETAMINOPHEN, COZAAR, METOPROLOL TARTRATE, ENOXAPARIN, IMOVANE, OXYCODONE. Patient was hospitalized. Patient died on 01/18/2007.Erlotinib Side Effects Report #5794565-5
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on June 11, 2008. Male patient, 64 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, oral intake reduced. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with METOCLOPRAMIDE, LOPERAMIDE, KYTRIL, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5935314-7
Erlotinib side effect was reported by a Physician from MEXICO on Oct 17, 2008. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, malignant neoplasm progression. Erlotinib dosage: (150 MG QD), ORAL. Patient died on 11/10/2005.
Erlotinib Side Effects Report #6140651-X
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Mar 16, 2009. Male patient, 64 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, hypophagia, malignant neoplasm progression. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with METOCLOPRAMIDE, LOPERAMIDE, KYTRIL, STILNOX, ONDANSETRON, SMECTITE. Patient was hospitalized. Patient died on 05/22/2008.
Erlotinib Side Effects Report #5889152-4
Erlotinib side effect was reported by a Health Professional from GERMANY on Sept 02, 2008. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac failure, malignant neoplasm progression, tachyarrhythmia. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with NEXIUM, IBUPROFEN, NOVALGIN, ZOMETA, DURAGESIC. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5900777-X
Erlotinib side effect was reported by a Health Professional from SWITZERLAND on Sept 12, 2008. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pleural effusion, pneumonia
, rhinitis. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5125147-6
Erlotinib side effect was reported by a Physician from ESTONIA on Sept 21, 2006. Male patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoglobin decreased, lung neoplasm malignant, malignant neoplasm progression, skin ulcer haemorrhage, soft tissue haemorrhage. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with FUROSEMIDE, SOTAHEXAL, ENALAPRIL MALEATE, IMDUR, IMOVANE, TRAMADOL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5832474-3
Erlotinib side effect was reported by a Physician from HUNGARY on July 16, 2008. Female patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, lung neoplasm malignant, malignant neoplasm progression. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with METHYLPREDNISOLONE, FAMOTIDINE. Patient was hospitalized. Patient died on 05/06/2008.
Erlotinib Side Effects Report #5856728-X
Erlotinib side effect was reported by a Health Professional from HUNGARY on Aug 05, 2008. Female patient, 61 years of age, weighting 58.00 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, non-small cell lung cancer. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with MTHYLPREDNISOLONE, FAMOTIDINE. Patient was hospitalized. Patient died on 05/06/2008.
Erlotinib Side Effects Report #6106824-7
Erlotinib side effect was reported by a Physician from JAPAN on Feb 17, 2009. Male patient, 61 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haematuria, interstitial lung disease, malignant neoplasm progression. Erlotinib dosage: (150 MG, QD), ORAL, (100 MG, QD), ORAL. During the same period patient was treated with LOPERAMIDE, GARENOXACIN MESILATE. Patient recovered.
Erlotinib Side Effects Report #6084768-7
Erlotinib side effect was reported by a Consumer or non-health professional from JAPAN on Feb 02, 2009. Female patient, 60 years of age, weighting 105.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gastroenteritis
, intestinal obstruction, lung adenocarcinoma, malignant neoplasm progression. Erlotinib dosage: (150 MG, QD), ORAL : (150 MG, QD), ORAL. During the same period patient was treated with FERROMIA, OMEPRAZOLE, FENTANYL. Patient was hospitalized. Patient died on 11/16/2008.Erlotinib Side Effects Report #6060255-7
Erlotinib side effect was reported by a Physician from POLAND on Jan 15, 2009. Female patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: fatigue, hypomagnesaemia, lung neoplasm malignant, malignant neoplasm progression, nausea
. Erlotinib dosage: unknown. During the same period patient was treated with AMARYL, MAGNESIUM, TRAMADOL, KETOPROFEN, OMEPRAZOLE, TORECAN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6125212-0
Erlotinib side effect was reported by a Health Professional from UKRAINE on Mar 03, 2009. Male patient, 59 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest pain
, coma, cough, dizziness , fatigue, gait disturbance, hypotension, malignant neoplasm progression, metastases to central nervous system. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LOPERAMIDE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5984665-9
Erlotinib side effect was reported by a Physician from SWITZERLAND on Nov 18, 2008. Female patient, 56 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: catheter sepsis, cholelithiasis, enterococcal sepsis, gastric neoplasm, gastrointestinal haemorrhage, malignant neoplasm progression, pancreatitis acute, pneumonia
. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, GEMZAR, CARBOPLATIN, AUGMENTIN, CLARITHROMYCIN, CEFEPIME, VANCOMYCIN, METHOTREXATE. Patient was hospitalized. Patient died on 09/21/2008.Erlotinib Side Effects Report #6023216-X
Erlotinib side effect was reported by a Physician from ARGENTINA on Dec 12, 2008. Male patient, 55 years of age, weighting 211.6 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, respiratory failure. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with ACETYLCYSTEINE, DEXAMETHASONE. Patient was hospitalized. Patient died on 10/25/2008.
Erlotinib Side Effects Report #5856827-2
Erlotinib side effect was reported by a Physician from SWITZERLAND on Aug 08, 2008. Female patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea, malignant neoplasm progression, respiratory failure. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, CISPLATIN. Patient was hospitalized and became disabled. Patient died on 07/14/2008.Erlotinib Side Effects Report #6099842-9
Erlotinib side effect was reported by a Physician from FRANCE on Feb 13, 2009. Female patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, lung neoplasm malignant, malignant neoplasm progression, treatment failure. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DOXYCYCLINE, FERROUS SULPHATE. Patient was hospitalized. Patient died on 01/30/2009.Erlotinib Side Effects Report #5466210-X
Erlotinib side effect was reported by a Physician from SWITZERLAND on Sept 04, 2007. Male patient, 50 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoptysis, hydropneumothorax, malignant neoplasm progression, non-small cell lung cancer. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient died on 12/18/2006.
Erlotinib Side Effects Report #5134568-7
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2006. Male patient, 47 years of age, weighting 196.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac arrest
, malignant neoplasm progression, myocardial infarction, non-small cell lung cancer. Erlotinib dosage: 150 MG (QD),ORAL. During the same period patient was treated with METHADONE, ATIVAN, MORPHINE, PREDNISONE, DUONEB, NITROGLYCERIN, ALBUTEROL SULPHATE, DOCUSATE. Patient died.Erlotinib Side Effects Report #5691960-X
Erlotinib side effect was reported by a Physician from BRAZIL on Feb 21, 2008. Female patient, 40 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, sepsis
. Erlotinib dosage: 150 MG QD ORAL. Patient died on 08/13/2005.Erlotinib Side Effects Report #5875348-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 22, 2008. Male patient, weighting 181.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, dyspnoea, fall , hyperkalaemia, malignant neoplasm progression, musculoskeletal chest pain, oedema peripheral, pleural effusion. Erlotinib dosage: (150 MG,QD), ORAL. Patient died.Erlotinib Side Effects Report #5997996-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 14, 2008. Male patient, weighting 128.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, haemoglobin decreased, haemoptysis, hypoxia, international normalised ratio increased, lung consolidation, lymphadenopathy mediastinal, malignant neoplasm progression, prothrombin time prolonged. Erlotinib dosage: (150 MG,GD), ORAL. During the same period patient was treated with SORAFENIB, COUMADIN, MORPHINE, CHLORPROMAZINE, LASIX, DURAGESIC. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6092991-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 10, 2009. Male patient, weighting 128.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, haemoglobin decreased, haemoptysis, hypoxia, malignant neoplasm progression, prothrombin time prolonged. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with COUMADIN, MORPHINE, CHLORPROMAZINE, LASIX, DURAGESIC, APIXTRA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6106518-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 17, 2009. Female patient, weighting 205.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, asthenia, blood pressure decreased, carotid artery disease
, depressed level of consciousness, lung neoplasm malignant, malignant neoplasm progression, metastases to liver. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with COMPLETE VITAMINS, ACTOS, LOW DOSE ASA, ZETIA, VITAMIN B12. Patient died.Erlotinib Side Effects Report #6120260-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 27, 2009. Female patient, 84 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, mental status changes, rectal haemorrhage. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with XOPENEX, IMDUR, ADVAIR HFA, LESCOL, TIOTROPIUM BROMIDE, CARAFATE, ZOCOR. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5979480-6
Erlotinib side effect was reported by a Physician from CHILE on Nov 14, 2008. Female patient, 66 years of age, weighting 130.1 lb, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: condition aggravated, dehydration, diarrhoea, diplopia, hypertension, malignant neoplasm progression, metastases to central nervous system, nausea
. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with EUTIROX, ENALAPRIL MALEATE, ALIPRAZOLAM, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient died on 09/23/2008.Erlotinib Side Effects Report #5530375-1
Erlotinib side effect was reported by a Consumer or non-health professional from GERMANY on Nov 19, 2007. Female patient, 65 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, lung neoplasm malignant, malignant neoplasm progression, superior vena caval occlusion. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with SYMBICORT, HYOSCINE HYT, CEPHALEXIN, METRONIDAZOLE. Patient was hospitalized. Patient died on 11/28/2006.
Erlotinib Side Effects Report #5652053-0
Erlotinib side effect was reported by a Health Professional from GERMANY on Feb 19, 2008. Female patient, 65 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, malignant neoplasm progression, non-small cell lung cancer, superior vena caval occlusion. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with SYMBICORT, HYOSCINE HYT, CEPHALEXIN, METRONIDAZOLE. Patient was hospitalized. Patient died on 11/28/2006.
Erlotinib Side Effects Report #6094382-5
Erlotinib side effect was reported by a Health Professional from FRANCE on Feb 09, 2009. Male patient, 53 years of age, was diagnosed with lung neoplasm malignant, non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebrovascular accident, coma, disease progression, malignant neoplasm progression, pleural effusion. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DOXYCYCLINE. Patient was hospitalized. Patient died on 01/21/2009.
Erlotinib Side Effects Report #6060257-0
Erlotinib side effect was reported by a Physician from JAPAN on Jan 14, 2009. Female patient, 87 years of age, weighting 74.74 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: lung adenocarcinoma, malignant neoplasm progression, malignant pleural effusion, respiratory failure. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with DIGOXIN. Patient died on 09/27/2008.
Erlotinib Side Effects Report #5891538-9
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 03, 2008. Male patient, 82 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: angina pectoris, folliculitis, malignant neoplasm progression, metastases to central nervous system, paronychia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with EVIPROSTAT, SENNOSIDES, NAIXAN, RIZE, GASMOTIN, MAGNESIUM OXIDE, PARIET, NOVAMIN. Patient died.
Erlotinib Side Effects Report #5900768-9
Erlotinib side effect was reported by a Physician from JAPAN on Sept 12, 2008. Female patient, 82 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: duodenal perforation, duodenal ulcer, hypercalcaemia, hyperlipidaemia, hypertension, malignant neoplasm progression, mental disorder. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GEFITINIB, IMIDAPRIL, NORVASC, PRAVASTATIN, NAPROXEN, REBAMIPIDE. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5979488-0
Erlotinib side effect was reported by a Physician from JAPAN on Nov 13, 2008. Male patient, 80 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral infarction, cerebral ischaemia, dehydration, delirium, diarrhoea, disseminated intravascular coagulation, lung adenocarcinoma, malignant neoplasm progression, metastases to bone. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LOXONIN, VOLTAREN, MUCOSTA, GABAPEN, LOPERAMIDE, LANSOPRAZOLE. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #6093031-X
Erlotinib side effect was reported by a Physician from JAPAN on Feb 10, 2009. Male patient, 79 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, lung adenocarcinoma, malignant neoplasm progression, rash
. Erlotinib dosage: 150 MG QD; ORAL. During the same period patient was treated with GASTER D, MAGMITT, BEZATOL. Patient died on 01/27/2009.Erlotinib Side Effects Report #6010179-6
Erlotinib side effect was reported by a Physician from JAPAN on Dec 01, 2008. Female patient, 78 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, eating disorder
, gastroduodenal ulcer, gastrointestinal oedema, lung adenocarcinoma, malignant neoplasm progression, nutritional condition abnormal. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BETAMETHASONE, FAMOTIDINE, DEPAS, RABEPRAZOLE, ALBUMIN TANNATE. Patient died on 04/21/2008.Erlotinib Side Effects Report #5839445-1
Erlotinib side effect was reported by a Physician from JAPAN on July 25, 2008. Male patient, 75 years of age, weighting 142.2 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: constipation
, erythema multiforme, gastrointestinal disorder, malignant neoplasm progression, no therapeutic response, pain , stevens-johnson syndrome, viral infection . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with ZONISAMIDE, DIPYRIDAMOLE, RAMITALATE, FAMOTIDINE, BETAMETHASONE. Patient died.Erlotinib Side Effects Report #5932698-0
Erlotinib side effect was reported by a Physician from JAPAN on Oct 08, 2008. Male patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood bilirubin increased, cataract
, hepatic function abnormal, herpes zoster, hypoxia, lung adenocarcinoma, malignant neoplasm progression, metastases to central nervous system, metastases to lymph nodes. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with POLYFUL, EURODIN, FAMOTIDINE, DOMPERIDONE, GASMOTIN, MAGNESIUM OXIDE, ZOLPIDEM TARTRATE. Patient died on 06/08/2008.Erlotinib Side Effects Report #5984679-9
Erlotinib side effect was reported by a Physician from JAPAN on Nov 17, 2008. Female patient, 75 years of age, weighting 143.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arterial thrombosis limb, malignant neoplasm progression, metastases to spine, non-small cell lung cancer stage iv. Erlotinib dosage: unknown. During the same period patient was treated with VITAMEDIN, METHYCOBAL, PRAVASTATIN, LOXONIN, SELBEX, NAUZELIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5839451-7
Erlotinib side effect was reported by a Physician from JAPAN on July 24, 2008. Female patient, 70 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, non-small cell lung cancer, platelet count decreased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with MOBIC. Patient was hospitalized. Patient died on 03/23/2008.
Erlotinib Side Effects Report #5891593-6
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 05, 2008. Female patient, 70 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, disseminated intravascular coagulation, malignant neoplasm progression, platelet count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MOBIC. Patient was hospitalized. Patient died on 03/23/2008.
Erlotinib Side Effects Report #6025190-9
Erlotinib side effect was reported by a Physician from JAPAN on Dec 15, 2008. Female patient, 70 years of age, weighting 122.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, malignant neoplasm progression, pain
, pruritus, rash , skin ulcer. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DIART, CELECOXIB, TIZANIDINE, MUCOSTA, HUSTAZOL, ALDACTONE, PREDNISOLONE, BROCIN. Patient died on 07/24/2008.Erlotinib Side Effects Report #6106850-8
Erlotinib side effect was reported by a Physician from JAPAN on Feb 17, 2009. Female patient, 70 years of age, weighting 122.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, malignant neoplasm progression, pain
, pruritus, rash , skin ulcer. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with DIART, CELECOXIB, TIZANIDINE, MUCOSTA, HUSTAZOL, ALDACTONE, PREDNISOLONE, BROCIN. Patient died on 07/24/2008.Erlotinib Side Effects Report #6106851-X
Erlotinib side effect was reported by a Physician from JAPAN on Feb 17, 2009. Male patient, 70 years of age, weighting 121.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dry skin, granulocytopenia, malignant neoplasm progression, neutropenia. Erlotinib dosage: 150 MG, QD, ORAL, 25 MG, QD, ORAL. During the same period patient was treated with AMARYL, GLUCOBAY, METHYCOBAL, ZYRTEC, PURSENNID, BROCIN, LANOCONAZOLE, ZOMETA. Patient died on 10/29/2008.
Erlotinib Side Effects Report #6121204-6
Erlotinib side effect was reported by a Physician from JAPAN on Feb 27, 2009. Female patient, 70 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, disseminated intravascular coagulation, malignant neoplasm progression, non-small cell lung cancer, platelet count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MOBIC. Patient was hospitalized. Patient died on 03/23/2008.
Erlotinib Side Effects Report #6094377-1
Erlotinib side effect was reported by a Health Professional from JAPAN on Feb 10, 2009. Male patient, 68 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiomegaly, infection
, interstitial lung disease, left ventricular dysfunction, malignant neoplasm progression, pericardial effusion, pleural effusion, pneumonia viral, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with AMLODIPINE BESYLATE, MICARDIS, HARNAL, BASEN, GLUFAST, NOVOLIN N, GASMOTIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5839447-5
Erlotinib side effect was reported by a Physician from JAPAN on July 25, 2008. Male patient, 67 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, malignant neoplasm progression, pneumonia klebsiella, rash
. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with MEDICON, BIOFERMIN, GOODMIN, ADONA, MUCOSOLVAN, ALLELOCK. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5880702-0
Erlotinib side effect was reported by a Health Professional from JAPAN on Aug 29, 2008. Male patient, 66 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: hyponatraemia, malignant neoplasm progression. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with MAGLAX HYPEN, PURSENNID, MUCOSTA, JUVELA. Patient died on 08/13/2008.
Erlotinib Side Effects Report #6132581-4
Erlotinib side effect was reported by a Physician from JAPAN on Mar 09, 2009. Male patient, 65 years of age, weighting 119.5 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, arteriovenous fistula, dermatitis acneiform, dizziness
, gastritis atrophic, lung adenocarcinoma, malignant neoplasm progression, melaena, pseudomembranous colitis. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with FAMOTIDINE, BETAMETHASONE, MUCOSTA, ZOLPIDEM, HOKUNALIN, MAXIPIME, VITAMEDIN, METOCLOPRAMIDE. Patient was hospitalized. Patient died on 01/30/2009.Erlotinib Side Effects Report #5735802-2
Erlotinib side effect was reported by a Physician from JAPAN on Apr 09, 2008. Female patient, 62 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, dysgeusia, hepatic function abnormal, lung consolidation, malignant neoplasm progression, pleural effusion. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with MORPHINE, PRIMPERAN, CALCIUM LACTATE, GLYCYRON, ALFAROL, SUCRALFATE, PREDNISOLONE. Patient died.
Erlotinib Side Effects Report #6025539-7
Erlotinib side effect was reported by a Physician from JAPAN on Dec 15, 2008. Male patient, 62 years of age, weighting 138.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: delirium, depression
, diarrhoea, hepatic function abnormal, interstitial lung disease, lung adenocarcinoma, malignant neoplasm progression, rash , restlessness. Erlotinib dosage: 150 MG, QD; ORAL. During the same period patient was treated with MYSLEE, DEPAKENE, GASMOTIN, METHYCOBAL, CYTOTEC, OXYCONTIN, NAIXAN, GASTROM. Patient died on 07/02/2008.Erlotinib Side Effects Report #6052263-7
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Male patient, 62 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: lung adenocarcinoma, malignant neoplasm progression, metastases to liver, metastases to peritoneum, peritonitis, rash
. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with MORPHINE, DICLOFENAC, REBAMIPIDE, DIAZEPAM. Patient died on 06/06/2008.Erlotinib Side Effects Report #6068758-6
Erlotinib side effect was reported by a Physician from JAPAN on Jan 19, 2009. Female patient, 61 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, diarrhoea, hepatic function abnormal, herpes zoster, ingrowing nail, lung adenocarcinoma, malignant neoplasm progression, rash papular. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with IRESSA, CARBOPLATIN, PACLITAXEL, TAXOTERE, GEMZAR, CISPLATIN, NAVELBINE. Patient died on 06/24/2008.
Erlotinib Side Effects Report #6140671-5
Erlotinib side effect was reported by a Health Professional from JAPAN on Mar 17, 2009. Female patient, 61 years of age, weighting 88.18 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, constipation
, diarrhoea, hepatic function abnormal, herpes zoster, ingrowing nail, lung adenocarcinoma, malignant neoplasm progression, metastases to adrenals. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with IRESSA, CARBOPLATIN, PACLITAXEL, TAXOTERE, GEMZAR, CISPLATIN, NAVELBINE. Patient died on 06/24/2008.Erlotinib Side Effects Report #5722246-2
Erlotinib side effect was reported by a Physician from JAPAN on Apr 11, 2008. Female patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, hyponatraemia, malignant neoplasm progression, oedema, rash
, white blood cell count increased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with OMEPRA, DEPAS, NORVASC, ZOLPIDEM TARTRATE. Patient died on 03/31/2008.Erlotinib Side Effects Report #6032046-4
Erlotinib side effect was reported by a Physician from JAPAN on Dec 23, 2008. Male patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, dermatitis acneiform, diarrhoea, hypochloraemia, hyponatraemia, lung adenocarcinoma, malignant neoplasm progression, performance status decreased. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with OXYCONTIN, MORPHINE, RINDERON, BACTRAMIN, LOXONIN, MUCOSTA. Patient was hospitalized. Patient died on 10/12/2008.
Erlotinib Side Effects Report #5979497-1
Erlotinib side effect was reported by a Health Professional from JAPAN on Nov 13, 2008. Male patient, 59 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumothorax. Erlotinib dosage: (150 MG, QD), ORAL (100 MG, QD), ORAL. During the same period patient was treated with NAIXAN, OPALMON, LOXOPROFEN, MAGMITT, FAMOTIDINE, GABAPEN, OXYCONTIN. Patient was hospitalized. Patient died on 10/03/2008.
Erlotinib Side Effects Report #6128210-6
Erlotinib side effect was reported by a Physician from JAPAN on Mar 06, 2009. Male patient, 59 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cheilitis, lung adenocarcinoma, malignant neoplasm progression, pneumothorax. Erlotinib dosage: 150 MG, QD, ORAL; 100 MG, QD, ORAL. During the same period patient was treated with NAIXAN, OPALMON, LOXOPROFEN, MAGMITT, GASTRER, GABAPEN, OXYCONTIN. Patient was hospitalized. Patient died on 10/03/2008.
Erlotinib Side Effects Report #6088095-3
Erlotinib side effect was reported by a Physician from JAPAN on Feb 05, 2009. Female patient, 58 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, depressed level of consciousness, diverticulum, duodenal ulcer, malignant neoplasm progression, melaena, metastases to bone, metastases to central nervous system. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with ZANTAC, LASIX, ALDACTONE, RIZE, DEPAS, ISOSORBIDE, GASMOTIN, AVELOX. Patient died on 12/12/2008.
Erlotinib Side Effects Report #6128103-4
Erlotinib side effect was reported by a Physician from JAPAN on Mar 04, 2009. Male patient, 57 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dermatitis acneiform, dysgeusia, lung adenocarcinoma, malignant neoplasm progression, pain of skin, stomatitis. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with LACTOBACILLUS CASE I, FLOMOX, FERROMIA, POVIDONE IODINE. Patient died.
Erlotinib Side Effects Report #6051350-7
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Female patient, 56 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood bilirubin increased, duodenal ulcer, lung adenocarcinoma, malignant neoplasm progression, rash
. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with LOXONIN, GASTER D, MAGLAX. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5839450-5
Erlotinib side effect was reported by a Physician from JAPAN on July 24, 2008. Male patient, 55 years of age, weighting 136.7 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, chronic obstructive pulmonary disease, hypophagia, lung neoplasm malignant, malignant neoplasm progression, metastases to adrenals, metastases to lung, pneumonia
, pulmonary embolism . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with VOLTAREN, LANSOPRAZOLE, BEZATROL, PRIMPERAN, NOVAMIN, OXYCONTIN. Patient was hospitalized. Patient died on 05/05/2008.Erlotinib Side Effects Report #5705281-X
Erlotinib side effect was reported by a Physician from JAPAN on Mar 27, 2008. Male patient, 53 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asphyxia, cardio-respiratory arrest, condition aggravated, disease progression, gastrointestinal haemorrhage, haematemesis, lung adenocarcinoma, malignant neoplasm progression, pulmonary haemorrhage. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with PREDNISOLONE, TAMSULOSIN, FAMOTIDINE, DEPAS, PURSENNID, ZOLPIDEM TARTRATE, MAGNESIUM OXIDE. Patient died on 03/08/2008.
Erlotinib Side Effects Report #5729797-5
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 16, 2008. Male patient, 52 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: convulsion, lung neoplasm malignant, malignant neoplasm progression, metastases to central nervous system. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with URSO, HOCHU, MOHRUS. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5836130-7
Erlotinib side effect was reported by a Physician from JAPAN on July 22, 2008. Male patient, 52 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, atrial septal defect, cardiovascular disorder, convulsion, dermatitis acneiform, diarrhoea, lung neoplasm malignant, malignant neoplasm progression, metastases to central nervous system. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with URSO, HOCHU, MOHRUS. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6051225-3
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Male patient, 50 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood amylase increased, lung adenocarcinoma, malignant neoplasm progression. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with FERROMIA, ACETAMINOPHEN, LENDORM, LOXONIN, MUCOSTA, OXYCONTIN, OXYCODONE, DUROTEP. Patient died on 12/11/2008.
Erlotinib Side Effects Report #5176325-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 21, 2006. Male patient, 52 years of age, was diagnosed with laryngeal cancer, disease progression and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, diarrhoea, faecal incontinence, haemoglobin decreased, lobar pneumonia, loss of consciousness, malignant neoplasm progression, metastases to bone. Erlotinib dosage: 150 MG (QD); ORAL. During the same period patient was treated with CISPLATIN, DOCETAXEL, PEMETREXED. Patient was hospitalized. Patient died on 11/07/2006.